Featuring perspectives from Dr Beth Faiman, Dr Natalie S
Callander, Dr Hans Lee and Dr Mary Steinbach, moderated by Dr
Callander, including the following topics:
Introduction (00:00)
Role of Chimeric Antigen Receptor T-Cell Therapy in
Relapsed/Refractory (R/R) MM (3:44)
Role of BCMA- and Non-BCMA-Targeted Bispecific Antibodies in
R/R MM (27:00)
Utility of Belantamab Mafodotin in R/R MM (49:29)
Potential Role of Cereblon E3 Ligase Modulators in MM
(1:07:01)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.